Taletrectinib
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Taletrectinib, covering 2025-05-01 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV) [Phase 3]